류마티스 관절염 환자에서 약사의 교육 전후에 따른 약물 인지도 변화
Evaluation of Medication Knowledge Before and After the Education Program by Pharmacists in Patients with Rheumatoid Arthritis
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Rheumatoid arthritis is a systemic inflammatory disease, causing chronic inflammation of the joints and multiple organs of the body. Long-term use of antirheumatic drugs is important for patients with rheumatoid arthritis. But in spite of long-term use of drugs, patients have little medication knowledge. Medication knowledge may increase the awareness about benefits and risks of the medicine and may improve adherence. Therefore, the purpose of this study was to examine the medication knowledge in patients with rheumatoid arthritis and to evaluate the change of drug awareness before and after education program by pharmacists and to identify the factors that influence medication knowledge. A total of 101 Korean patients with rheumatoid arthritis were enrolled from the Rheumatologic Clinic of Seoul National University Hospital. The patients’ medication knowledges were assessed before education and again at next visit. Medication knowledge was calculated by (the number of drugs recognized)/(the number of drugs prescribed)×100%. For identifying the factors that influence medication knowledge, we collected information about the participants. At first estimation before education, patients’ medication knowledges about drug names, purpose of use, dosage, major adverse reaction were 36.6(±39.3)%, 37.6(±34.7)%, 96.0(±9.7)%, and 10.2(±24.8)%, respectively. At second estimation, all items improved to 53.1(±40.8)%, 69.8(±32.0)%, 98.0(±7.0)%, and 43.9(±37.8)%, respectively. The mean medication knowledge of 4 items increased from 45.1(±19.6)% to 66.2(±22.9)% (p<0.001). Age, the number of drugs prescribed, dosing frequency, education level and employment status were significantly related to medication knowledge. In this study, we confirmed that the medication knowledge can be improved by education program of pharmacists.
Abstract
Rheumatoid arthritis is a systemic inflammatory disease, causing chronic inflammation of the joints and multiple organs of the body. Long-term use of antirheumatic drugs is important for patients with rheumatoid arthritis. But in spite of long-term use of drugs, patients have little medication knowledge. Medication knowledge may increase the awareness about benefits and risks of the medicine and may improve adherence. Therefore, the purpose of this study was to examine the medication knowledge in patients with rheumatoid arthritis and to evaluate the change of drug awareness before and after education program by pharmacists and to identify the factors that influence medication knowledge. A total of 101 Korean patients with rheumatoid arthritis were enrolled from the Rheumatologic Clinic of Seoul National University Hospital. The patients’ medication knowledges were assessed before education and again at next visit. Medication knowledge was calculated by (the number of drugs recognized)/(the number of drugs prescribed)×100%. For identifying the factors that influence medication knowledge, we collected information about the participants. At first estimation before education, patients’ medication knowledges about drug names, purpose of use, dosage, major adverse reaction were 36.6(±39.3)%, 37.6(±34.7)%, 96.0(±9.7)%, and 10.2(±24.8)%, respectively. At second estimation, all items improved to 53.1(±40.8)%, 69.8(±32.0)%, 98.0(±7.0)%, and 43.9(±37.8)%, respectively. The mean medication knowledge of 4 items increased from 45.1(±19.6)% to 66.2(±22.9)% (p<0.001). Age, the number of drugs prescribed, dosing frequency, education level and employment status were significantly related to medication knowledge. In this study, we confirmed that the medication knowledge can be improved by education program of pharmacists.
참고문헌 (16)
- Emery P., "Treatment of rh eumatoid arthritis", BMJ, 332, pp.152~155 (2006)
- Mahmud T., "Clinical implications of patients' knowledge", Clin Rheumatol, 14(6), pp.627~630 (1995)
- Shen Q., "Duvall D. : Evaluation of a medicationeducation program for elderly hospital in-patients", Geriatr Nurs, 27(3), pp.184~192 (2006)
- Barat l., "Damsgaard EM. Drug therapy in the elderly: what doctors believe and patients actually do", Br J ClinPharmacol, 51(6), pp.615~622 (2001)
- N u esch R., "Relationbetween insufficient response to antihy-pertensive treatment and poor compliance with treatment a prospective case-con- trol study", BMJ, 323, pp.142~146 (2001)
- Waeber B., "Improved blood pres-sure control by monitoring compliance with ant ihypertensive therapy", In t J Clin Pract, 53, pp.37~38 (1999)
- Kamata Y, "Rheumatoidarthritis complicated with acute intersti-tial pneumonia induced by leflunomide as an adverse reaction", Intern Med, 43(12), pp.1201~1204 (2004)
- Jobanputra P., "Hepatotoxicity associated with sulfasalazine in inflam- matory arthritis: A case series from a local surveillance of serious adverse events", pp.9~48 (2008), BMC Musculoskelet Disord
- Wolfe F., "Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease modifying antirheumatic drugs, and anti- tumor necrosis factor therapy", Arthritis Rheum, 54(2), pp.628~634 (2006)
- Minocha A., "Pi ttsley RA. Liver cirrhosis in rheumatoid arthritis patients treated with long-term methotrexate", Vet Hum Toxicol, 35(1), pp.45~48 (1993)
- Machado M., "Sensitivity of patient outcomes to pharmacist inter- ventions. Part III: systematic review and meta - analysis in hyperli pidemia man- agement", Ann Pharmacother, 42(9), pp.1195~1207 (2008)
- Machado M., "Einarson TR : Sensitivity of patient out- comes to pharmacist interventions. Part II: Systematic review and meta-analysis in hypertension management", Ann Pharmacother, 41(11), pp.1770~1781 (2007)
- Wubben DP., "Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a system- atic review", Pharmacotherapy, 28(4), pp.421~436 (2008)
- Elliott RA, "The cost effectiveness of a telephone-based pharmacy advisory service to improve adherence to newly prescribed medicines", Pharm World Sci, 30(1), pp.17~23 (2008)
- Schuh MJ, "Cognitive serv-ices provided by pharmacists: is the public willing to pay for them?", Consult Pharm, 23(3), pp.223~230 (2008)
- Oh Y., "Pharmacist time requirements for counseling in an outpatient pharmacy", Am J Health syst Pharm, 59(23), pp.2346~2355 (2002)